Eder JP - Search Results

1

Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948).

Raut CP, Boucher Y, Duda DG, Morgan JA, Quek R, Ancukiewicz M, Lahdenranta J, Eder JP, Demetri GD, Jain RK. Raut CP, et al. Among authors: eder jp. PLoS One. 2012;7(2):e26331. doi: 10.1371/journal.pone.0026331. Epub 2012 Feb 7. PLoS One. 2012. PMID: 22347360 Free PMC article. Clinical Trial.

2

Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies.

Ryan DP, Supko JG, Eder JP, Seiden MV, Demetri G, Lynch TJ, Fischman AJ, Davis J, Jimeno J, Clark JW. Ryan DP, et al. Among authors: eder jp. Clin Cancer Res. 2001 Feb;7(2):231-42. Clin Cancer Res. 2001. PMID: 11234874 Clinical Trial.

3

Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors.

Clark JW, Eder JP, Ryan D, Lathia C, Lenz HJ. Clark JW, et al. Among authors: eder jp. Clin Cancer Res. 2005 Aug 1;11(15):5472-80. doi: 10.1158/1078-0432.CCR-04-2658. Clin Cancer Res. 2005. PMID: 16061863 Clinical Trial.

4

A phase I study of foretinib, a multi-targeted inhibitor of c-Met and vascular endothelial growth factor receptor 2.

Eder JP, Shapiro GI, Appleman LJ, Zhu AX, Miles D, Keer H, Cancilla B, Chu F, Hitchcock-Bryan S, Sherman L, McCallum S, Heath EI, Boerner SA, LoRusso PM. Eder JP, et al. Clin Cancer Res. 2010 Jul 1;16(13):3507-16. doi: 10.1158/1078-0432.CCR-10-0574. Epub 2010 May 14. Clin Cancer Res. 2010. PMID: 20472683 Clinical Trial.

5

A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours.

Penson RT, Seiden MV, Matulonis UA, Appleman LJ, Fuller AF, Goodman A, Campos SM, Clark JW, Roche M, Eder JP. Penson RT, et al. Among authors: eder jp. Br J Cancer. 2005 Jul 11;93(1):54-9. doi: 10.1038/sj.bjc.6602671. Br J Cancer. 2005. PMID: 15986034 Free PMC article. Clinical Trial.

6

A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumors.

Ryan DP, O'Neil BH, Supko JG, Rocha Lima CM, Dees EC, Appleman LJ, Clark J, Fidias P, Orlowski RZ, Kashala O, Eder JP, Cusack JC Jr. Ryan DP, et al. Among authors: eder jp. Cancer. 2006 Dec 1;107(11):2688-97. doi: 10.1002/cncr.22280. Cancer. 2006. PMID: 17075878 Free article. Clinical Trial.

7

A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors.

Wong KK, Fracasso PM, Bukowski RM, Lynch TJ, Munster PN, Shapiro GI, Jänne PA, Eder JP, Naughton MJ, Ellis MJ, Jones SF, Mekhail T, Zacharchuk C, Vermette J, Abbas R, Quinn S, Powell C, Burris HA. Wong KK, et al. Among authors: eder jp. Clin Cancer Res. 2009 Apr 1;15(7):2552-8. doi: 10.1158/1078-0432.CCR-08-1978. Epub 2009 Mar 24. Clin Cancer Res. 2009. PMID: 19318484 Clinical Trial.

8

Phase I clinical trial of 7-cyanoquinocarcinol (DX-52-1) in adult patients with refractory solid malignancies.

Bunnell CA, Supko JG, Eder JP Jr, Clark JW, Lynch TJ, Kufe DW, Shulman LN. Bunnell CA, et al. Among authors: eder jp jr. Cancer Chemother Pharmacol. 2001 Nov;48(5):347-55. doi: 10.1007/s002800100319. Cancer Chemother Pharmacol. 2001. PMID: 11761451 Clinical Trial.

9

Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily.

Eder JP Jr, Supko JG, Clark JW, Puchalski TA, Garcia-Carbonero R, Ryan DP, Shulman LN, Proper J, Kirvan M, Rattner B, Connors S, Keogan MT, Janicek MJ, Fogler WE, Schnipper L, Kinchla N, Sidor C, Phillips E, Folkman J, Kufe DW. Eder JP Jr, et al. J Clin Oncol. 2002 Sep 15;20(18):3772-84. doi: 10.1200/JCO.2002.02.082. J Clin Oncol. 2002. PMID: 12228197 Clinical Trial.

10

Phase I clinical trial and pharmacokinetic study of the spicamycin analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients with refractory solid tumors.

Supko JG, Eder JP Jr, Ryan DP, Seiden MV, Lynch TJ, Amrein PC, Kufe DW, Clark JW. Supko JG, et al. Among authors: eder jp jr. Clin Cancer Res. 2003 Nov 1;9(14):5178-86. Clin Cancer Res. 2003. PMID: 14613997 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page